Open Access

[Corrigendum] A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties

  • Authors:
    • Xiaofeng Han
    • Fangfang Du
    • Li Jiang
    • Yifei Zhu
    • Zhen Chen
    • Yanjun Liu
    • Tingting Hong
    • Teng Wang
    • Yong Mao
    • Xiaohong Wu
    • Iain C. Bruce
    • Jian Jin
    • Xin Ma
    • Dong Hua
  • View Affiliations

  • Published online on: September 26, 2022     https://doi.org/10.3892/ol.2022.13526
  • Article Number: 406
  • Copyright : © Han et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

November-2022
Volume 24 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Han X, Du F, Jiang L, Zhu Y, Chen Z, Liu Y, Hong T, Wang T, Mao Y, Wu X, Wu X, et al: [Corrigendum] A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties. Oncol Lett 24: 406, 2022
APA
Han, X., Du, F., Jiang, L., Zhu, Y., Chen, Z., Liu, Y. ... Hua, D. (2022). [Corrigendum] A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties. Oncology Letters, 24, 406. https://doi.org/10.3892/ol.2022.13526
MLA
Han, X., Du, F., Jiang, L., Zhu, Y., Chen, Z., Liu, Y., Hong, T., Wang, T., Mao, Y., Wu, X., Bruce, I. C., Jin, J., Ma, X., Hua, D."[Corrigendum] A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties". Oncology Letters 24.5 (2022): 406.
Chicago
Han, X., Du, F., Jiang, L., Zhu, Y., Chen, Z., Liu, Y., Hong, T., Wang, T., Mao, Y., Wu, X., Bruce, I. C., Jin, J., Ma, X., Hua, D."[Corrigendum] A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties". Oncology Letters 24, no. 5 (2022): 406. https://doi.org/10.3892/ol.2022.13526